Methods of cancer diagnosis using a chimeric toxin

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/62 (2006.01) C07K 7/23 (2006.01) C07K 14/21 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2323786

The present invention relates to methods for cancer diagnosis using a chimeric toxin. In particular, the invention relates to the use of a chimeric toxin composed of gonadotropin releasing hormone (GnRH) and Pseudomonas exotoxin A (PE) to detect a tumor-associated epitope expressed by human adenocarcinomas. Mutated GnRH-PE molecules that bind but do not kill tumor cells are exemplified.

L'invention concerne des procédés servant à diagnostiquer le cancer au moyen d'une toxine chimère. Elle concerne, en particulier, l'utilisation d'une toxine chimère composée d'une hormone de libération de gonadotrophine (GnRH) et d'une exotoxine A de Pseudomonas (PE) afin de détecter un déterminant antigénique associé à une tumeur et exprimé par des adénocarcinomes humains. Elle cite pour exemple des molécules de GnRH-PE ayant subi une mutation et qui se fixent aux cellules cancéreuses sans les détruire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of cancer diagnosis using a chimeric toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of cancer diagnosis using a chimeric toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of cancer diagnosis using a chimeric toxin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1942271

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.